The observation that MUC16 is present on T cells is interesting, because recently it has been shown that Siglec-9 is overexpressed on T cells from the ascites and tumor-invading lymphocytes (TILs) of ovarian [29] and other tumors, such as head and neck tumors [30] or acute myeloid leukemia [31]. This evidence concerns the gene MUC16 and head and neck neoplasm.